SCHEMBL4308274

SCHEMBL4308274

NC(=O)Nc1cc(CNc2ncsc2C(=O)Nc2ccc3c(c2)OC(F)(F)C(F)(F)O3)ccn1

nearest known ligand 0.73

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KIT P10721 20/20 0.73
BRAF P15056 20/20 0.73
MAPK1 P28482 2/20 0.59
AKT1 P31749 2/20 0.59
KDR P35968 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4314938 0.96 KIT (0.73) KITBRAFMAPK1AKT1KDR
SCHEMBL4316690 0.92 KIT (0.76) KITBRAFMAPK1AKT1KDR
SCHEMBL4316706 0.90 KIT (0.79) KITBRAFMAPK1AKT1KDR
SCHEMBL4305949 0.89 KIT (0.77) KITBRAFMAPK1AKT1KDR
SCHEMBL4305954 0.89 KIT (0.75) KITBRAFMAPK1AKT1KDR
SCHEMBL4307151 0.89 KIT (0.72) KITBRAFMAPK1AKT1KDR
SCHEMBL4310818 0.89 KIT (0.69) KITBRAFMAPK1AKT1KDR
SCHEMBL4312332 0.89 KIT (0.72) KITBRAFMAPK1AKT1KDR
SCHEMBL4307187 0.89 KIT (0.69) KITBRAFMAPK1AKT1KDR
SCHEMBL4316636 0.88 KIT (0.73) KITBRAFMAPK1AKT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023753-A1 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents BAYER HEALTHCARE AG (DE) 2009-01-22 US disclosed
US-20090023753-A1 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents BAYER HEALTHCARE AG (DE) 2009-01-22 US disclosed
US-20090023753-A1 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents BAYER HEALTHCARE AG (DE) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023753-A1 1,3-Thiazole-5-Carboxamides Useful as Cancer Chemotherapeutic Agents MCL1, HDAC5, HDAC6 KIT 2658/4885BRAF 1099/4885MAPK1 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.